Methods for increasing production of 3-methyl-2-butenol using fusion proteins

US9631210B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9631210-B2
Application numberUS-201214345147-A
CountryUS
Kind codeB2
Filing dateSep 13, 2012
Priority dateSep 14, 2011
Publication dateApr 25, 2017
Grant dateApr 25, 2017

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention relates to methods and compositions for increasing production of 3-methyl-2-butenol in a de novo synthetic pathway in a genetically modified host cell using isopentenyl disphosphate (IPP) as a substrate.

First claim

Opening claim text (preview).

What is claimed is: 1. A genetically modified host cell transformed with a nucleic acid construct encoding a fusion protein comprising a phosphatase capable of catalyzing the dephosphorylation of dimethylallyl diphosphate (DMAPP) linked to an isopentyl pyrophosphate (IPP) isomerase capable of converting IPP to DMAPP, wherein the nucleic acid construct is operably linked to a promoter. 2. The genetically modified host cell of claim 1 , wherein the genetically modified host cell further comprises a nucleic acid encoding a reductase that is capable of converting 3-methyl-2-butenol to 3-methy-butanol. 3. The genetically modified host cell of claim 2 , wherein the reductase is encoded by a nucleic acid construct introduced into the cell. 4. The genetically modified host cell of claim 1 , wherein the IPP isomerase is a Type I isomerase. 5. The genetically modified host cell of claim 4 , wherein the IPP isomerase is encoded by the E. coli idi gene or the Saccharomyces cerevisiae idil gene. 6. The genetically modified host cell of claim 1 , wherein the phosphatase is a member of the Nudix superfamily. 7. The genetically modified host cell of claim 6 , wherein the phosphatase is encoded by the E. coli nudB gene. 8. The genetically modified host cell of claim 1 , wherein the host cell is a prokaryotic cell selected from Escherichia, Enterobacter, Azotobacter, Erwinia, Bacillus, Pseudomonas, Klebsielia, Proteus, Salmonella, Serratia, Shigella, Rhizobia , Vitreoscilla, Synechococcus, Synechocystis , or Paracoccus taxonomical classes. 9. The genetically modified host cell of claim 8 , wherein the prokaryotic cell is an Escherichia coli cell. 10. The genetically modified host cell of claim 1 , wherein the host cell is a fungal cell. 11. The genetically modified host cell of claim 10 , wherein the fungal cell is a yeast cell. 12. The genetically modified host cell of claim 11 , wherein the yeast cell is a Saccharomyces sp. cell. 13. The genetically modified host cell of claim 1 , wherein the host cell is an algal, insect or mammalian cell line. 14. The genetically modified host cell of claim 1 , wherein the IPP isomerase is encoded by the E. coli idi gene or the Saccharomyces cerevisiae idil gene; and the phosphatase is encoded by the E. coli nudB gene. 15. The genetically modified host cell of claim 14 , wherein the host cell is a prokaryotic cell. 16. The genetically modified host cell of claim 15 , wherein the host cell is a prokaryotic cell selected from Escherichia, Enterobacter, Azotobacter, Erwinia, Bacillus, Pseudomonas, Klebsielia, Proteus, Salmonella, Serratia, Shigella, Rhizobia, Vitreoscilla, Synechococcus, Synechocystis , or Paracoccus taxonomical classes. 17. The genetically modified host cell of claim 15 , wherein the prokaryotic cell is an Escherichia coli cell. 18. A method of enhancing production of a 3-methyl-2-butenol, the method comprising culturing a genetically modified host cell transformed with a nucleic acid construct encoding a fusion protein comprising a phosphatase capable of catalyzing the dephosphorylation of DMAPP linked to IPP isomerase capable of converting IPP to DMAPP, wherein the nucleic acid construct is operably linked to a promoter, under conditions such that the culturing results in the expression of the fusion protein and production of 3-methyl-2-butenol. 19. The method of claim 18 , further comprising recovering 3-methyl-2-butenol produced by the genetically modified host cell. 20. The method of claim 18 , wherein the genetically modified host cell further comprises a nucleic acid encoding a reductase such that expression of the reductase converts 3-methyl-2-butenol to 3-methyl butanol. 21. The method of claim 20 , wherein the reductase is encoded by a nucleic acid construct introduced into the genetically modified host cell. 22. The method of claim 20 , further comprising recovering 3-methyl-2-butenol or 3-methyl butanol produced by the genetically modified host cell. 23. The method of claim 18 , wherein the IPP isomerase is a Type I isomerase. 24. The method of claim 23 , wherein the IPP isomerase is encoded by the E. coli idi gene or the Saccharomyces cerevisiae idil gene. 25. The method of claim 18 , wherein the phosphatase is a member of the Nudix superfamily. 26. The method of claim 25 , wherein the phosphatase is encoded by the E. coli nudB gene. 27. The method of claim 18 , wherein the genetically modified host cell is a prokaryotic cell selected from Escherichia, Enterobacter, Azotobacter, Erwinia, Bacillus, Pseudomonas, Klebsielia, Proteus, Salmonella, Serratia, Shigella, Rhizobia, Vitreoscilla, Synechococcus, Synechocystis , or Paracoccus taxonomical classes. 28. The method of claim 27 , wherein the prokaryotic cell is an Escherichia coli cell. 29. The method of claim 18 , wherein the genetically modified host cell is a fungal cell. 30. The method of claim 29 , wherein the fungal cell is a yeast cell. 31. The method of claim 30 , wherein the yeast cell is a Saccharomyces sp. cell. 32. The method of claim 18 , wherein the genetically modified host cell is an algal, insect or mammalian cell line. 33. The method of claim 18 , wherein the IPP isomerase is encoded by the E. coli idi gene or the Saccharomyces cerevisiae idil gene; and the phosphatase is encoded by the E. coli nudB gene. 34. The method of claim 33 , wherein the genetically modified host cell is a prokaryotic cell. 35. The method of claim 34 , wherein the prokaryotic cell is selected from Escherichia, Enterobacter, Azotobacter, Erwinia, Bacillus, Pseudomonas, Klebsielia, Proteus, Salmonella, Serratia, Shigella, Rhizobia , Vitreoscilla, Synechococcus, Synechocystis , or Paracoccus taxonomical classes. 36. The method of claim 34 , wherein the prokaryotic cell is an Escherichia coli cell.

Assignees

Inventors

Classifications

  • Isomerases (5.) · CPC title

  • C12P7/16Primary

    Butanols · CPC title

  • Biofuels, e.g. bio-diesel · CPC title

  • Isopentenyl-diphosphate DELTA-isomerase (5.3.3.2) · CPC title

  • DNA sequences coding for fusion proteins · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9631210B2 cover?
The present invention relates to methods and compositions for increasing production of 3-methyl-2-butenol in a de novo synthetic pathway in a genetically modified host cell using isopentenyl disphosphate (IPP) as a substrate.
Who is the assignee on this patent?
Chou Howard, Keasling Jay D, Univ California
What technology area does this patent fall under?
Primary CPC classification C12P7/16. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Apr 25 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).